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Abstract 
Background/Objective: Although the REV-ERBα is considered an important regulator of 
both clock function and metabolism, its relationship with sleep duration and obesity is 
less clear. The objective of this study was to examine the association between the REV-
ERBα clock gene and two outcomes – sleep duration and body mass index (BMI) – in 
European adolescents. 
Methods: A sample of 831 adolescents (392 boys) aged 11.5–18.8 years from 10 
European centers was used. The independent variables were REV-ERBα rs2071427 and 
rs2071570 SNPs, and their respective haplotypes. The outcomes were sleep duration 
and BMI.  
Results: In girls, no significant association were found between rs2071427 or rs2071570 
and the studied outcomes (p≥0.43). In boys, however, significant associations were 
found between rs2071570 and sleep duration (β: –0.32 hours/day for T minor allele 
carriers; p=0.0017), and rs2071427 and BMI (β: +0.72 kg/m2 for A minor allele 
carriers; p=0.016). In the haplotype analysis, the TA haplotype (carrying the two minor 
alleles) was associated with both lower sleep duration (–0.38 hours/day; p=0.05) 
and higher BMI (+1.41 kg/m2; p=0.018) in boys, when compared with the common 
CC haplotype.  
Conclusions: The REV-ERBα rs2071427 and rs2071570 were associated with both sleep 
duration and BMI in boys. These findings confirmed the relevance of the REV-ERBα 
gene in human obesity, primarily in males, and also suggested that it has a potential role 
in affecting sleep duration. 
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Introduction 
Based on the day-night cycle, the circadian rhythm provides appropriate timing 
efficiency in biological systems through the synchronization of behavior and physiology 
[1-3]. Metabolic homeostasis and the circadian clock (rhythm) are intimately linked in 
mammals [4]; moreover, misalignment of the circadian rhythm has been associated with 
metabolic abnormalities in humans [2] and in animal models [5,6]. In addition, it is 
currently accepted that these associations are modulated by clock genes (eg, CLOCK, 
BMAL1, RORα, REV-ERBα) [2,7-9].  
Among clock genes, the REV-ERBα (also known as NR1D1) is considered an 
important regulator of both clock function [10] and metabolism [11,12]. In short, this 
gene modulates the fine-tuning of circadian rhythmicity, in that BMAL1 activates REV-
ERBα transcription and then REV-ERBα represses the transcription of BMAL1 [7]. 
Specifically, studies on genetic variations of REV-ERBα have shown that rs2314339, 
rs2071427 and rs2071570 single-nucleotide polymorphisms (SNPs) are associated with 
obesity in adults [13,14] and youths [4]. Literature suggests a connection between the 
biological clock and obesity-related traits [14] and, more recently, it has been shown 
that REV-ERBα could modulate obesity in a sex-specific manner [13].  
Although a link between REV-ERBα and obesity has been found [4,3,14], few 
studies have examined whether the association can vary depending on sex. Furthermore, 
it is believed that there are no studies that address the impact of REV-ERBα on sleep 
duration in humans. The current study examined the association between two REV-
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ERBα SNPs (rs2071427 and rs2071570) and sleep duration, as well as BMI in European 
adolescents stratified by sex. 
 
Methods 
Subjects 
The subjects were evaluated in the Healthy Lifestyle in Europe by Nutrition in 
Adolescence (HELENA) study, a cross-sectional study comprised of 3528 adolescents 
from 10 European cities (11.5–18.8 years) who were recruited between 2006 and 2007. 
One third of the study population was randomly selected for blood collection (n = 
1155). After removing the participants who had missing values for REV-ERB SNPs, 
BMI, sleep duration and confounding factors, the sample used in the present study was 
set at 831 (47% boys). The study was performed following the ethical guidelines of the 
Declaration of Helsinki and was approved by the Research Ethics Committee of each 
city involved. Written, informed consent was obtained from each subject and their 
parent(s) or guardian(s) [15]. A detailed description of the methodology used in the 
HELENA study has been published elsewhere [16]. 
 
SNP selection and genotyping 
The REV-ERBα rs2071427 and rs2071570 (also tagged as rs939347) SNPs were 
selected as independent variables based on previously published studies in which they 
were associated with health outcomes [4,10,13]. These SNPs are located in the intron 1 
and the promoter of the NR1D1 gene, respectively. Genotyping was carried out through 
fasting blood samples collected by venipuncture after a 10-hour overnight fast. The 
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SNPs were genotyped using Illumina technology. The processes for obtaining and 
genotyping the blood samples have been described in detail elsewhere [4,17].  
 
 
Outcomes 
Sleep duration and body mass index (BMI) were considered dependent variables. Sleep 
duration was estimated using a questionnaire that included the following questions: 
“During weekdays: how many hours (and minutes) do you usually sleep?” and “During 
weekend days: how many hours (and minutes) do you usually sleep?” [18]. Self-
reported sleep duration was calculated as: 
 [(mean sleep duration on weekdays x 5) + (mean sleep duration on days during the 
weekend x 2)]/7 [19].  
The questionnaire was shown to be reliable, Cohen’s weighted k statistic was 0.81 and 
0.96 for weekdays and days during the weekend, respectively [18]. The adolescents’ 
heights were measured to the nearest 0.1 cm, barefoot and in the Frankfort plane, with a 
telescopic stadiometer (SECA 225) and their weight were measured to the nearest 0.1 
kg, in underwear and barefoot, with an electronic portable digital scale (SECA 861 
type) [20]. BMI was calculated by dividing weight (kg) by height (m2). 
 
Potential confounders 
Potential confounders were age (years), center (cities), maternal education and tobacco 
consumption. Maternal education was assessed using a self-reported questionnaire and 
classified into four levels: elementary education, lower secondary education, upper 
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secondary education and university degree. Tobacco consumption was defined as 
regular consumption over the week, varying between “no smoking” to “smoking every 
day”.  
 
Statistical analysis 
The Stata 12 (Stata Corp., College Station, TX, USA) program was used for statistical 
analysis. For the descriptive analyses, mean and 95% of confidence intervals (95% CI) 
were calculated for quantitative variables. Differences between the means were 
analyzed by Student’s t-test (two means) for unpaired samples. A linear trend test was 
performed to check the distribution of categorical variables. The significance level was 
set at p≤0.05.  
Hardy-Weinberg equilibrium was tested using the Chi-squared test (1 degree of 
freedom). The significance level was set at p≤0.05. The linkage disequilibrium (LD) 
between the rs2071427 and rs2071570 SNPs was calculated based on the equations 
shown by Pritchard et al. [21]. Linear regression analyses were preformed to assess 
association between the two SNPs – rs2071427 and rs2071570 – and (i) sleep duration 
and (ii) BMI according to the additive genetic model [22], adjusted for potential 
confounders. Potential confounders with p-values of ≤0.20 were retained in the 
multivariate model. The major allele was used as the reference. Bonferroni correction 
was applied to control for multiple testing in the genetic analyses (p≤0.05 per two SNPs 
tested, resulting in p≤0.025) [22].  
Interaction between sex and sleep duration or BMI was tested by adding an 
interaction term SNP*sex to the GLM model. Haplotype analysis was carried out using 
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the Thesias software [23], stratified by sex. The haplotype analyses were adjusted for 
potential confounders. The significance level was set at p≤0.05.  
 
Results 
The characteristics of the subjects are presented in Table 1. Sleep duration was higher in 
boys than in girls. BMI was similar between boys and girls. There were no differences 
in terms of maternal education and smoking habits between the sexes.  
Table 2 shows the genotype distributions of the REV-ERBα rs2071427 and 
rs2071570 SNPs. The minor allele frequencies were 0.28 and 0.21, respectively, and the 
Hardy-Weinberg equilibrium was observed for each SNP (p=0.45 and p=0.76, 
respectively). A weak LD was found between REV-ERBα rs2071427 and rs2071570 
SNPs (D' = 0.286 and r2 = 0.048). 
The associations between the REV-ERBα SNPs and sleep duration and BMI are 
presented in Table 3. Although no significant interaction between the SNPs and sex 
could be detected, the analyses were stratified by sex as (i) sleep duration varied for 
males and females in the HELENA study [19] and (ii) Ruano et al. [13] showed 
different associations between REV-ERBα SNPs and obesity in each sex. No significant 
association could be detected in girls; however, boys carrying the minor T allele of 
rs2071427 had a higher BMI than C allele carriers (= +0.72 kg/m², p=0.018). In 
addition, boys carrying the minor A allele of rs2071570 had lower sleep duration than C 
allele carriers (= –0.32 hours/day, p=0.0019). These associations remained significant 
after adjustment for potential confounders and were independent of each other.  
In addition, haplotype analyses were performed, revealing that the rs2071427 
and rs2071570 SNPs generate four haplotypes (frequency ranging 0.10–0.60). As for 
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individual SNP analyses, no significant association could be detected in girls (data not 
shown). In boys, despite a non-significant haplotype global effect on BMI, the TA 
haplotype (including the two minor alleles) was associated with higher BMI (+1.41 
kg/m², p=0.018) compared with the reference CC haplotype (Table 4). This association 
was not modified by adjustment for sleep duration. With regards to sleep duration, there 
was a significant global haplotype effect, and both the TC and TA haplotypes were 
associated with lower sleep duration (–0.41, p=0.008 and –0.38 hours/day, p=0.05, 
respectively). These associations persisted after adjustment for BMI.  
 
 
Discussion 
A significant association was found between REV-ERBα rs2071427 and rs2071570 
variants and both sleep duration and BMI, confirming previous findings of an 
association in humans between REV-ERBα and obesity phenotype [10,11,13,14] and 
adding evidence to the connection between REV-ERBα and sleep duration. Associations 
between REV-ERBα and sleep duration and BMI differed significantly by sex. Based on 
the data, the minor alleles of rs2071427 and rs2071570 were associated with higher 
BMI and lower sleep duration in boys, respectively. The haplotype carrying the two 
minor alleles was also associated with both higher BMI and lower sleep duration in 
boys, with effect sizes superior to those of the individual SNPs.  
These findings suggest a potential link between REV-ERBα and sleep duration, 
with a possible specific role for each sex. Although the REV-ERBα gene circadian 
expression in peripheral tissues in both humans [8,11,24] and in animal models [6,7] is 
well documented, studies on REV-ERBα and sleep duration or circadian rhythms are 
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scarce. A recent study of humans showed associations between polymorphisms of this 
gene and circadian typologies (circadian preferences: evening type, intermediate, 
morning type) [10]. In knockout mice, Mang et al. provided important proof that REV-
ERBα is involved in the sleep homeostatic phenotype [25]. Consistent with the current 
findings, lack of REV-ERBα may lead to deficits in engaging in waking behaviors such 
as exploratory behavior in mice [25]. In this sense, REV-ERBα could thus act as a sensor 
of the metabolic imbalance imposed at the neuronal level by periods of extended 
wakefulness, which is in keeping with the current proposal that clock genes not only set 
time of day, but in the cerebral cortex can also be used to keep track of and respond to 
time spent awake [26]. Another study, with animal models, showed that the absence of 
normal function in the PER1 and PER2 clock genes seemed to protect male mice from 
metabolic reprogramming, suggesting that the circadian timing system has a role in 
regulating the physiological effects of sleep disruption [5]. It could be a potential and 
partial explanation for the association between REV-ERBα rs2071570 SNP and sleep 
duration found exclusively in boys in the current study. 
In addition, the current study found an association between the REV-ERBα 
rs2071427 polymorphism and BMI in boys. This result is consistent with previous 
studies showing associations between rs2071427 polymorphism and obesity phenotype 
(higher BMI) [13,14]. The current study also found an association between the TA 
haplotype (carrying the minor alleles for both rs2071427 and rs2071570 SNPs) and 
BMI. The REV-ERBα gene could favor a visceral accumulation of fat [7], especially in 
males [13], showing a different role of adipogenesis among males and females. In a 
study with animal models, Bugge et al. [7] showed the possible mechanisms of REV-
ERBα influencing the clock function and mediating the interplay between circadian 
rhythms and metabolism. One of the most important mechanisms could be the hepatic 
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phosphatidylcholine regulated by the circadian clock through a BMAL1-REV-ERBα-
CHKα axis, which suggests that an intact circadian timing system is important for the 
temporal coordination of phospholipid metabolism [27].  
The current study showed results supporting the association between REV-ERBα 
with decreasing sleep duration (around 20 minutes per day) and increasing BMI (around 
1 kg/m²) in boys. However, it remains uncertain whether specific metabolites that vary 
according to time of day and nutrient status (fasting vs feeding) may also affect the 
circadian function of energy-sensing neurons [2]. The mere perturbation of metabolic 
homeostasis with a high-fat diet is sufficient to alter the clock gene function [28]. 
Conversely, in mice, treatment of diet-induced obesity with REV-ERB agonist decreased 
obesity by reducing fat mass and markedly improving dyslipidemia and hyperglycemia, 
indicating REV-ERB as a potential pharmacological target for treatment of sleep 
disorders and metabolic diseases [29].  
The major limiting factors in this study were: (i) its cross-sectional design, 
which does not allow for causal relationships to be observed; (ii) the use of a self-
reported questionnaire to identify sleep duration; and (iii) although there is marked 
interest in the literature to elucidate the role of REV-ERBα rs2071427 and rs2071570 
SNPs, the current subjects potentially affected by these minor alleles were 7% and 4%, 
respectively. Another limitation of this study was that analyses could not be adjusted for 
circadian typology (circadian preferences: evening type, intermediate, morning type), 
which is an outcome associated with REV-ERBα [10]. In addition, according to 
conceptual epidemiological framework [30], it was not possible to adjust the analysis of 
other factors potentially associated with BMI in either of the two models, such as 
physical activity and dietary patterns, because they are in the causative variables line. 
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In contrast, the present study had several strengths. Firstly, this was the first time 
that REV-ERBα has been studied in relation to sleep duration. Secondly, it confirmed 
the association between REV-ERBα and BMI through replication, a process by which 
genetic association results are validated [22]. This was also the first time that a REV-
ERBα haplotype has been associated with both sleep duration and BMI. Additional 
studies in other populations are necessary to confirm the generalizability of these 
findings, and this study must be replicated in different age groups. Further genetic 
studies are needed to understand the REV-ERBα mechanisms in circadian clocks and 
circadian disorders. 
 
 
Conclusions 
REV-ERBα rs2071427 and rs2071570 were associated with sleep duration and BMI in 
boys. These findings confirm the relevance of REV-ERBα in human obesity, primarily 
in males, and also suggest that it has a potential role in affecting sleep duration. It is 
suggested that REV-ERBα be a target gene in the treatment of obesity. 
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Table 1. Characteristics of the participating subjects in the HELENA study. 
 
Variables 
Mean ± SD or % (n) 
Male (n = 392) Female (n = 439) p-valueŦ 
      
Age, years 14.7 ± 1.5 14.6 ± 1.4 0.47 
Sleep duration, hours/day 8.2 ± 1.2 8.0 ± 1.2 0.0076 
BMI, kg/m2 21.6 ± 4.1 21.4 ± 3.5 0.41 
Maternal education, % (n)     0.24 
Lower education 7.1 (28) 9.3 (41)  
Lower secondary education 27.3 (107) 26.4 (116)  
Higher secondary education 31.9 (125) 35.1 (154)  
University degree 33.7 (132) 29.2 (128)  
Tobacco consumption, % (n)     0.62 
No smoking  82.9 (325) 82.0 (360)  
Less than once a week 5.4 (21) 3.9 (17)  
At least once a week, but not every 
day 
3.6 (14) 3.4 (15)  
Every day 8.1 (32) 10.7 (47)  
Significant values are in bold (p≤0.05). 
BMI, body mass index; SD, standard deviation. 
Ŧ p-value for t-test. 
ŦŦ p-value for linear trend test. 
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Table 2. Genotype distributions of the REV-ERBα SNPs in the participating subjects of 
the HELENA study. 
REV-ERBα SNPs n Frequency MAF H-W p-value 
rs2071427 
CC 431 0.52 0.28 0.45 
CT 341 0.41 
TT 59 0.07 
Total 831 
rs2071570 
CC 514 0.62 0.21 0.76 
CA 281 0.34 
AA 36 0.04 
Total 831       
H-W, Hardy-Weinberg; MAF, minor allele frequency; SNPs, single nucleotide 
polymorphisms. 
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Table 3. Associations between REV-ERBα SNPs and sleep duration and BMI by sex.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significant values are in bold (p≤0.025). 
BMI, body mass index; h/d, hours/day; SE, Standard error.  
Beta coefficients are calculated with an additive model (minor allele effect).  
a
 p-values adjusted for age, center, maternal education and tobacco consumption. 
b
 p-values adjusted for age, center, maternal education, tobacco consumption and BMI.      
c
 p-values adjusted for age, center, maternal education, tobacco consumption and sleep time.      
 Males (n = 392) 
  β coefficient SE pa pb pc 
rs2071427       
sleep duration (h/d)  –0.17 0.09 0.06 0.052 – 
BMI (kg/m²)  0.72 0.30 0.018 – 0.016 
       
rs2071570       
sleep duration (h/d)  –0.32 0.10 0.0019 0.0017 – 
BMI (kg/m²)  0.60 0.35 0.09 – 0.07 
       
 Females (n = 439) 
  β coefficient SE pa pb pc 
rs2071427       
sleep duration (h/d)  0.001 0.09 0.99 0.99 – 
BMI (kg/m²)  0.03 0.27 0.90 – 0.90 
       
rs2071570       
sleep duration (h/d)  –0.07 0.09 0.44 0.42 – 
BMI (kg/m²)  –0.22 0.29 0.45 – 0.43 
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Table 4. REV-ERBα haplotype frequencies and haplotype effects on BMI and sleep duration in boys (n = 392).    
Significant values are in bold (p≤0.05).  
BMI, body mass index; h/d, hours/day; SE, Standard error. 
Data are difference in means ± SE compared with the CC reference haplotype.  
Single nucleotide polymorphisms (SNPs) were used in the following order: rs2071427 and rs2071570. 
p-values were adjusted for age, center, maternal education and tobacco consumption. 
 
Haplotype 
rs2071427/rs2071570 
Frequency 
 BMI (kg/m²)  Sleep duration (h/d) 
 ∆ ± SE 
Global effect  
(p-value) 
Haplotype effect  
(p-value)  ∆ ± SE 
Global effect 
 (p-value) 
Haplotype effect  
(p-value) 
CC 0.60  reference 
0.17 
–  reference 
0.005 
– 
CA 0.19  0.24 ± 0.40 0.47  –0.17 ± 0.13 0.10 
TC 0.11  0.04 ± 0.62 0.84  –0.41 ± 0.16 0.008 
TA 0.10  1.41 ± 0.46 0.018  –0.38 ± 0.16 0.05 
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Highlights 
• The REV-ERBα gene was associated with both sleep duration and body mass 
index in boys.  
• The REV-ERBα gene was found to play an important role in human obesity, 
primarily in males. 
• The REV-ERBα gene was found to have a potential role in sleep duration. 
 
 
 
